VAERS Explorer
Back to explore

Report #2854174

Received Aug 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
MI
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATIONUNK——

Symptoms (1)

Antibody test negative

Symptom narrative

Family Member is a Non-Responder; Initial report received on 25-Jul-2025. A physician reported that a patient received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and was a non-responder. No medical history or concomitant medications were reported. On an unknown date, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On an unknown date, after receiving HEPLISAV-B, the patient was identified as a non-responder. The reporter was inquiring if the patient was protected against hepatitis B virus. No other information was reported. Company Comment: The company assessed the event as non-serious. The dosing schedule of Heplisav-B and the serological marker was not reported.; Sender's Comments: The company assessed the event as non-serious. The dosing schedule of Heplisav-B and the serological marker was not reported.